Medical Devices & Consumables
Global Humanized Immune System (HIS) Models Market Research Report 2025
- Aug 11, 25
- ID: 430429
- Pages: 81
- Figures: 89
- Views: 4
This report aims to provide a comprehensive presentation of the global market for Humanized Immune System (HIS) Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humanized Immune System (HIS) Models.
The Humanized Immune System (HIS) Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Humanized Immune System (HIS) Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humanized Immune System (HIS) Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Taconic Biosciences
Inotiv
Jackson Laboratory
Janvier
Crown Bioscience
GenOway
Oncodesign Services
Champions Oncology
Miltenyi Biotec
BioDuro
GemPharmatech
Shanghai Model Organisms
Biocytogen
Segment by Type
Mouse
Rat
Segment by Application
Research Institutes
Pharmaceutical Companies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Humanized Immune System (HIS) Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Humanized Immune System (HIS) Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Humanized Immune System (HIS) Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humanized Immune System (HIS) Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Taconic Biosciences
Inotiv
Jackson Laboratory
Janvier
Crown Bioscience
GenOway
Oncodesign Services
Champions Oncology
Miltenyi Biotec
BioDuro
GemPharmatech
Shanghai Model Organisms
Biocytogen
Segment by Type
Mouse
Rat
Segment by Application
Research Institutes
Pharmaceutical Companies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Humanized Immune System (HIS) Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Humanized Immune System (HIS) Models Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mouse
1.2.3 Rat
1.3 Market by Application
1.3.1 Global Humanized Immune System (HIS) Models Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Humanized Immune System (HIS) Models Market Perspective (2020-2031)
2.2 Global Humanized Immune System (HIS) Models Growth Trends by Region
2.2.1 Global Humanized Immune System (HIS) Models Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Humanized Immune System (HIS) Models Historic Market Size by Region (2020-2025)
2.2.3 Humanized Immune System (HIS) Models Forecasted Market Size by Region (2026-2031)
2.3 Humanized Immune System (HIS) Models Market Dynamics
2.3.1 Humanized Immune System (HIS) Models Industry Trends
2.3.2 Humanized Immune System (HIS) Models Market Drivers
2.3.3 Humanized Immune System (HIS) Models Market Challenges
2.3.4 Humanized Immune System (HIS) Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Humanized Immune System (HIS) Models Players by Revenue
3.1.1 Global Top Humanized Immune System (HIS) Models Players by Revenue (2020-2025)
3.1.2 Global Humanized Immune System (HIS) Models Revenue Market Share by Players (2020-2025)
3.2 Global Top Humanized Immune System (HIS) Models Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Humanized Immune System (HIS) Models Revenue
3.4 Global Humanized Immune System (HIS) Models Market Concentration Ratio
3.4.1 Global Humanized Immune System (HIS) Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Humanized Immune System (HIS) Models Revenue in 2024
3.5 Global Key Players of Humanized Immune System (HIS) Models Head office and Area Served
3.6 Global Key Players of Humanized Immune System (HIS) Models, Product and Application
3.7 Global Key Players of Humanized Immune System (HIS) Models, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Humanized Immune System (HIS) Models Breakdown Data by Type
4.1 Global Humanized Immune System (HIS) Models Historic Market Size by Type (2020-2025)
4.2 Global Humanized Immune System (HIS) Models Forecasted Market Size by Type (2026-2031)
5 Humanized Immune System (HIS) Models Breakdown Data by Application
5.1 Global Humanized Immune System (HIS) Models Historic Market Size by Application (2020-2025)
5.2 Global Humanized Immune System (HIS) Models Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Humanized Immune System (HIS) Models Market Size (2020-2031)
6.2 North America Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
6.4 North America Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Humanized Immune System (HIS) Models Market Size (2020-2031)
7.2 Europe Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
7.4 Europe Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Humanized Immune System (HIS) Models Market Size (2020-2031)
8.2 Asia-Pacific Humanized Immune System (HIS) Models Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2020-2025)
8.4 Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Humanized Immune System (HIS) Models Market Size (2020-2031)
9.2 Latin America Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
9.4 Latin America Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Humanized Immune System (HIS) Models Market Size (2020-2031)
10.2 Middle East & Africa Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
10.4 Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Humanized Immune System (HIS) Models Introduction
11.1.4 Charles River Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Taconic Biosciences
11.2.1 Taconic Biosciences Company Details
11.2.2 Taconic Biosciences Business Overview
11.2.3 Taconic Biosciences Humanized Immune System (HIS) Models Introduction
11.2.4 Taconic Biosciences Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.2.5 Taconic Biosciences Recent Development
11.3 Inotiv
11.3.1 Inotiv Company Details
11.3.2 Inotiv Business Overview
11.3.3 Inotiv Humanized Immune System (HIS) Models Introduction
11.3.4 Inotiv Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.3.5 Inotiv Recent Development
11.4 Jackson Laboratory
11.4.1 Jackson Laboratory Company Details
11.4.2 Jackson Laboratory Business Overview
11.4.3 Jackson Laboratory Humanized Immune System (HIS) Models Introduction
11.4.4 Jackson Laboratory Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.4.5 Jackson Laboratory Recent Development
11.5 Janvier
11.5.1 Janvier Company Details
11.5.2 Janvier Business Overview
11.5.3 Janvier Humanized Immune System (HIS) Models Introduction
11.5.4 Janvier Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.5.5 Janvier Recent Development
11.6 Crown Bioscience
11.6.1 Crown Bioscience Company Details
11.6.2 Crown Bioscience Business Overview
11.6.3 Crown Bioscience Humanized Immune System (HIS) Models Introduction
11.6.4 Crown Bioscience Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.6.5 Crown Bioscience Recent Development
11.7 GenOway
11.7.1 GenOway Company Details
11.7.2 GenOway Business Overview
11.7.3 GenOway Humanized Immune System (HIS) Models Introduction
11.7.4 GenOway Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.7.5 GenOway Recent Development
11.8 Oncodesign Services
11.8.1 Oncodesign Services Company Details
11.8.2 Oncodesign Services Business Overview
11.8.3 Oncodesign Services Humanized Immune System (HIS) Models Introduction
11.8.4 Oncodesign Services Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.8.5 Oncodesign Services Recent Development
11.9 Champions Oncology
11.9.1 Champions Oncology Company Details
11.9.2 Champions Oncology Business Overview
11.9.3 Champions Oncology Humanized Immune System (HIS) Models Introduction
11.9.4 Champions Oncology Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.9.5 Champions Oncology Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Humanized Immune System (HIS) Models Introduction
11.10.4 Miltenyi Biotec Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.10.5 Miltenyi Biotec Recent Development
11.11 BioDuro
11.11.1 BioDuro Company Details
11.11.2 BioDuro Business Overview
11.11.3 BioDuro Humanized Immune System (HIS) Models Introduction
11.11.4 BioDuro Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.11.5 BioDuro Recent Development
11.12 GemPharmatech
11.12.1 GemPharmatech Company Details
11.12.2 GemPharmatech Business Overview
11.12.3 GemPharmatech Humanized Immune System (HIS) Models Introduction
11.12.4 GemPharmatech Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.12.5 GemPharmatech Recent Development
11.13 Shanghai Model Organisms
11.13.1 Shanghai Model Organisms Company Details
11.13.2 Shanghai Model Organisms Business Overview
11.13.3 Shanghai Model Organisms Humanized Immune System (HIS) Models Introduction
11.13.4 Shanghai Model Organisms Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.13.5 Shanghai Model Organisms Recent Development
11.14 Biocytogen
11.14.1 Biocytogen Company Details
11.14.2 Biocytogen Business Overview
11.14.3 Biocytogen Humanized Immune System (HIS) Models Introduction
11.14.4 Biocytogen Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.14.5 Biocytogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Humanized Immune System (HIS) Models Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mouse
1.2.3 Rat
1.3 Market by Application
1.3.1 Global Humanized Immune System (HIS) Models Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Humanized Immune System (HIS) Models Market Perspective (2020-2031)
2.2 Global Humanized Immune System (HIS) Models Growth Trends by Region
2.2.1 Global Humanized Immune System (HIS) Models Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Humanized Immune System (HIS) Models Historic Market Size by Region (2020-2025)
2.2.3 Humanized Immune System (HIS) Models Forecasted Market Size by Region (2026-2031)
2.3 Humanized Immune System (HIS) Models Market Dynamics
2.3.1 Humanized Immune System (HIS) Models Industry Trends
2.3.2 Humanized Immune System (HIS) Models Market Drivers
2.3.3 Humanized Immune System (HIS) Models Market Challenges
2.3.4 Humanized Immune System (HIS) Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Humanized Immune System (HIS) Models Players by Revenue
3.1.1 Global Top Humanized Immune System (HIS) Models Players by Revenue (2020-2025)
3.1.2 Global Humanized Immune System (HIS) Models Revenue Market Share by Players (2020-2025)
3.2 Global Top Humanized Immune System (HIS) Models Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Humanized Immune System (HIS) Models Revenue
3.4 Global Humanized Immune System (HIS) Models Market Concentration Ratio
3.4.1 Global Humanized Immune System (HIS) Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Humanized Immune System (HIS) Models Revenue in 2024
3.5 Global Key Players of Humanized Immune System (HIS) Models Head office and Area Served
3.6 Global Key Players of Humanized Immune System (HIS) Models, Product and Application
3.7 Global Key Players of Humanized Immune System (HIS) Models, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Humanized Immune System (HIS) Models Breakdown Data by Type
4.1 Global Humanized Immune System (HIS) Models Historic Market Size by Type (2020-2025)
4.2 Global Humanized Immune System (HIS) Models Forecasted Market Size by Type (2026-2031)
5 Humanized Immune System (HIS) Models Breakdown Data by Application
5.1 Global Humanized Immune System (HIS) Models Historic Market Size by Application (2020-2025)
5.2 Global Humanized Immune System (HIS) Models Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Humanized Immune System (HIS) Models Market Size (2020-2031)
6.2 North America Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
6.4 North America Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Humanized Immune System (HIS) Models Market Size (2020-2031)
7.2 Europe Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
7.4 Europe Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Humanized Immune System (HIS) Models Market Size (2020-2031)
8.2 Asia-Pacific Humanized Immune System (HIS) Models Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2020-2025)
8.4 Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Humanized Immune System (HIS) Models Market Size (2020-2031)
9.2 Latin America Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
9.4 Latin America Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Humanized Immune System (HIS) Models Market Size (2020-2031)
10.2 Middle East & Africa Humanized Immune System (HIS) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2020-2025)
10.4 Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Humanized Immune System (HIS) Models Introduction
11.1.4 Charles River Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Taconic Biosciences
11.2.1 Taconic Biosciences Company Details
11.2.2 Taconic Biosciences Business Overview
11.2.3 Taconic Biosciences Humanized Immune System (HIS) Models Introduction
11.2.4 Taconic Biosciences Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.2.5 Taconic Biosciences Recent Development
11.3 Inotiv
11.3.1 Inotiv Company Details
11.3.2 Inotiv Business Overview
11.3.3 Inotiv Humanized Immune System (HIS) Models Introduction
11.3.4 Inotiv Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.3.5 Inotiv Recent Development
11.4 Jackson Laboratory
11.4.1 Jackson Laboratory Company Details
11.4.2 Jackson Laboratory Business Overview
11.4.3 Jackson Laboratory Humanized Immune System (HIS) Models Introduction
11.4.4 Jackson Laboratory Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.4.5 Jackson Laboratory Recent Development
11.5 Janvier
11.5.1 Janvier Company Details
11.5.2 Janvier Business Overview
11.5.3 Janvier Humanized Immune System (HIS) Models Introduction
11.5.4 Janvier Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.5.5 Janvier Recent Development
11.6 Crown Bioscience
11.6.1 Crown Bioscience Company Details
11.6.2 Crown Bioscience Business Overview
11.6.3 Crown Bioscience Humanized Immune System (HIS) Models Introduction
11.6.4 Crown Bioscience Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.6.5 Crown Bioscience Recent Development
11.7 GenOway
11.7.1 GenOway Company Details
11.7.2 GenOway Business Overview
11.7.3 GenOway Humanized Immune System (HIS) Models Introduction
11.7.4 GenOway Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.7.5 GenOway Recent Development
11.8 Oncodesign Services
11.8.1 Oncodesign Services Company Details
11.8.2 Oncodesign Services Business Overview
11.8.3 Oncodesign Services Humanized Immune System (HIS) Models Introduction
11.8.4 Oncodesign Services Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.8.5 Oncodesign Services Recent Development
11.9 Champions Oncology
11.9.1 Champions Oncology Company Details
11.9.2 Champions Oncology Business Overview
11.9.3 Champions Oncology Humanized Immune System (HIS) Models Introduction
11.9.4 Champions Oncology Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.9.5 Champions Oncology Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Humanized Immune System (HIS) Models Introduction
11.10.4 Miltenyi Biotec Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.10.5 Miltenyi Biotec Recent Development
11.11 BioDuro
11.11.1 BioDuro Company Details
11.11.2 BioDuro Business Overview
11.11.3 BioDuro Humanized Immune System (HIS) Models Introduction
11.11.4 BioDuro Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.11.5 BioDuro Recent Development
11.12 GemPharmatech
11.12.1 GemPharmatech Company Details
11.12.2 GemPharmatech Business Overview
11.12.3 GemPharmatech Humanized Immune System (HIS) Models Introduction
11.12.4 GemPharmatech Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.12.5 GemPharmatech Recent Development
11.13 Shanghai Model Organisms
11.13.1 Shanghai Model Organisms Company Details
11.13.2 Shanghai Model Organisms Business Overview
11.13.3 Shanghai Model Organisms Humanized Immune System (HIS) Models Introduction
11.13.4 Shanghai Model Organisms Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.13.5 Shanghai Model Organisms Recent Development
11.14 Biocytogen
11.14.1 Biocytogen Company Details
11.14.2 Biocytogen Business Overview
11.14.3 Biocytogen Humanized Immune System (HIS) Models Introduction
11.14.4 Biocytogen Revenue in Humanized Immune System (HIS) Models Business (2020-2025)
11.14.5 Biocytogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Humanized Immune System (HIS) Models Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Mouse
Table 3. Key Players of Rat
Table 4. Global Humanized Immune System (HIS) Models Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Humanized Immune System (HIS) Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Humanized Immune System (HIS) Models Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Humanized Immune System (HIS) Models Market Share by Region (2020-2025)
Table 8. Global Humanized Immune System (HIS) Models Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Humanized Immune System (HIS) Models Market Share by Region (2026-2031)
Table 10. Humanized Immune System (HIS) Models Market Trends
Table 11. Humanized Immune System (HIS) Models Market Drivers
Table 12. Humanized Immune System (HIS) Models Market Challenges
Table 13. Humanized Immune System (HIS) Models Market Restraints
Table 14. Global Humanized Immune System (HIS) Models Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Humanized Immune System (HIS) Models Market Share by Players (2020-2025)
Table 16. Global Top Humanized Immune System (HIS) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Immune System (HIS) Models as of 2024)
Table 17. Ranking of Global Top Humanized Immune System (HIS) Models Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Humanized Immune System (HIS) Models Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Humanized Immune System (HIS) Models, Headquarters and Area Served
Table 20. Global Key Players of Humanized Immune System (HIS) Models, Product and Application
Table 21. Global Key Players of Humanized Immune System (HIS) Models, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Humanized Immune System (HIS) Models Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Humanized Immune System (HIS) Models Revenue Market Share by Type (2020-2025)
Table 25. Global Humanized Immune System (HIS) Models Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Humanized Immune System (HIS) Models Revenue Market Share by Type (2026-2031)
Table 27. Global Humanized Immune System (HIS) Models Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Humanized Immune System (HIS) Models Revenue Market Share by Application (2020-2025)
Table 29. Global Humanized Immune System (HIS) Models Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Humanized Immune System (HIS) Models Revenue Market Share by Application (2026-2031)
Table 31. North America Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Humanized Immune System (HIS) Models Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 46. Charles River Company Details
Table 47. Charles River Business Overview
Table 48. Charles River Humanized Immune System (HIS) Models Product
Table 49. Charles River Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. Taconic Biosciences Company Details
Table 52. Taconic Biosciences Business Overview
Table 53. Taconic Biosciences Humanized Immune System (HIS) Models Product
Table 54. Taconic Biosciences Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 55. Taconic Biosciences Recent Development
Table 56. Inotiv Company Details
Table 57. Inotiv Business Overview
Table 58. Inotiv Humanized Immune System (HIS) Models Product
Table 59. Inotiv Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 60. Inotiv Recent Development
Table 61. Jackson Laboratory Company Details
Table 62. Jackson Laboratory Business Overview
Table 63. Jackson Laboratory Humanized Immune System (HIS) Models Product
Table 64. Jackson Laboratory Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 65. Jackson Laboratory Recent Development
Table 66. Janvier Company Details
Table 67. Janvier Business Overview
Table 68. Janvier Humanized Immune System (HIS) Models Product
Table 69. Janvier Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 70. Janvier Recent Development
Table 71. Crown Bioscience Company Details
Table 72. Crown Bioscience Business Overview
Table 73. Crown Bioscience Humanized Immune System (HIS) Models Product
Table 74. Crown Bioscience Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 75. Crown Bioscience Recent Development
Table 76. GenOway Company Details
Table 77. GenOway Business Overview
Table 78. GenOway Humanized Immune System (HIS) Models Product
Table 79. GenOway Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 80. GenOway Recent Development
Table 81. Oncodesign Services Company Details
Table 82. Oncodesign Services Business Overview
Table 83. Oncodesign Services Humanized Immune System (HIS) Models Product
Table 84. Oncodesign Services Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 85. Oncodesign Services Recent Development
Table 86. Champions Oncology Company Details
Table 87. Champions Oncology Business Overview
Table 88. Champions Oncology Humanized Immune System (HIS) Models Product
Table 89. Champions Oncology Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 90. Champions Oncology Recent Development
Table 91. Miltenyi Biotec Company Details
Table 92. Miltenyi Biotec Business Overview
Table 93. Miltenyi Biotec Humanized Immune System (HIS) Models Product
Table 94. Miltenyi Biotec Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 95. Miltenyi Biotec Recent Development
Table 96. BioDuro Company Details
Table 97. BioDuro Business Overview
Table 98. BioDuro Humanized Immune System (HIS) Models Product
Table 99. BioDuro Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 100. BioDuro Recent Development
Table 101. GemPharmatech Company Details
Table 102. GemPharmatech Business Overview
Table 103. GemPharmatech Humanized Immune System (HIS) Models Product
Table 104. GemPharmatech Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 105. GemPharmatech Recent Development
Table 106. Shanghai Model Organisms Company Details
Table 107. Shanghai Model Organisms Business Overview
Table 108. Shanghai Model Organisms Humanized Immune System (HIS) Models Product
Table 109. Shanghai Model Organisms Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 110. Shanghai Model Organisms Recent Development
Table 111. Biocytogen Company Details
Table 112. Biocytogen Business Overview
Table 113. Biocytogen Humanized Immune System (HIS) Models Product
Table 114. Biocytogen Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 115. Biocytogen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Humanized Immune System (HIS) Models Picture
Figure 2. Global Humanized Immune System (HIS) Models Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Humanized Immune System (HIS) Models Market Share by Type: 2024 VS 2031
Figure 4. Mouse Features
Figure 5. Rat Features
Figure 6. Global Humanized Immune System (HIS) Models Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Humanized Immune System (HIS) Models Market Share by Application: 2024 VS 2031
Figure 8. Research Institutes Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Humanized Immune System (HIS) Models Report Years Considered
Figure 11. Global Humanized Immune System (HIS) Models Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Humanized Immune System (HIS) Models Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Humanized Immune System (HIS) Models Market Share by Region: 2024 VS 2031
Figure 14. Global Humanized Immune System (HIS) Models Market Share by Players in 2024
Figure 15. Global Humanized Immune System (HIS) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Humanized Immune System (HIS) Models Revenue in 2024
Figure 17. North America Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 19. United States Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 23. Germany Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Ireland Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Humanized Immune System (HIS) Models Market Share by Region (2020-2031)
Figure 31. China Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia & New Zealand Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 39. Mexico Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 43. Israel Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Charles River Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 47. Taconic Biosciences Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 48. Inotiv Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 49. Jackson Laboratory Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 50. Janvier Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 51. Crown Bioscience Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 52. GenOway Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 53. Oncodesign Services Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 54. Champions Oncology Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 55. Miltenyi Biotec Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 56. BioDuro Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 57. GemPharmatech Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 58. Shanghai Model Organisms Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 59. Biocytogen Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Humanized Immune System (HIS) Models Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Mouse
Table 3. Key Players of Rat
Table 4. Global Humanized Immune System (HIS) Models Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Humanized Immune System (HIS) Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Humanized Immune System (HIS) Models Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Humanized Immune System (HIS) Models Market Share by Region (2020-2025)
Table 8. Global Humanized Immune System (HIS) Models Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Humanized Immune System (HIS) Models Market Share by Region (2026-2031)
Table 10. Humanized Immune System (HIS) Models Market Trends
Table 11. Humanized Immune System (HIS) Models Market Drivers
Table 12. Humanized Immune System (HIS) Models Market Challenges
Table 13. Humanized Immune System (HIS) Models Market Restraints
Table 14. Global Humanized Immune System (HIS) Models Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Humanized Immune System (HIS) Models Market Share by Players (2020-2025)
Table 16. Global Top Humanized Immune System (HIS) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Immune System (HIS) Models as of 2024)
Table 17. Ranking of Global Top Humanized Immune System (HIS) Models Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Humanized Immune System (HIS) Models Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Humanized Immune System (HIS) Models, Headquarters and Area Served
Table 20. Global Key Players of Humanized Immune System (HIS) Models, Product and Application
Table 21. Global Key Players of Humanized Immune System (HIS) Models, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Humanized Immune System (HIS) Models Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Humanized Immune System (HIS) Models Revenue Market Share by Type (2020-2025)
Table 25. Global Humanized Immune System (HIS) Models Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Humanized Immune System (HIS) Models Revenue Market Share by Type (2026-2031)
Table 27. Global Humanized Immune System (HIS) Models Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Humanized Immune System (HIS) Models Revenue Market Share by Application (2020-2025)
Table 29. Global Humanized Immune System (HIS) Models Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Humanized Immune System (HIS) Models Revenue Market Share by Application (2026-2031)
Table 31. North America Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Humanized Immune System (HIS) Models Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Humanized Immune System (HIS) Models Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Humanized Immune System (HIS) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Humanized Immune System (HIS) Models Market Size by Country (2026-2031) & (US$ Million)
Table 46. Charles River Company Details
Table 47. Charles River Business Overview
Table 48. Charles River Humanized Immune System (HIS) Models Product
Table 49. Charles River Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. Taconic Biosciences Company Details
Table 52. Taconic Biosciences Business Overview
Table 53. Taconic Biosciences Humanized Immune System (HIS) Models Product
Table 54. Taconic Biosciences Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 55. Taconic Biosciences Recent Development
Table 56. Inotiv Company Details
Table 57. Inotiv Business Overview
Table 58. Inotiv Humanized Immune System (HIS) Models Product
Table 59. Inotiv Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 60. Inotiv Recent Development
Table 61. Jackson Laboratory Company Details
Table 62. Jackson Laboratory Business Overview
Table 63. Jackson Laboratory Humanized Immune System (HIS) Models Product
Table 64. Jackson Laboratory Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 65. Jackson Laboratory Recent Development
Table 66. Janvier Company Details
Table 67. Janvier Business Overview
Table 68. Janvier Humanized Immune System (HIS) Models Product
Table 69. Janvier Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 70. Janvier Recent Development
Table 71. Crown Bioscience Company Details
Table 72. Crown Bioscience Business Overview
Table 73. Crown Bioscience Humanized Immune System (HIS) Models Product
Table 74. Crown Bioscience Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 75. Crown Bioscience Recent Development
Table 76. GenOway Company Details
Table 77. GenOway Business Overview
Table 78. GenOway Humanized Immune System (HIS) Models Product
Table 79. GenOway Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 80. GenOway Recent Development
Table 81. Oncodesign Services Company Details
Table 82. Oncodesign Services Business Overview
Table 83. Oncodesign Services Humanized Immune System (HIS) Models Product
Table 84. Oncodesign Services Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 85. Oncodesign Services Recent Development
Table 86. Champions Oncology Company Details
Table 87. Champions Oncology Business Overview
Table 88. Champions Oncology Humanized Immune System (HIS) Models Product
Table 89. Champions Oncology Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 90. Champions Oncology Recent Development
Table 91. Miltenyi Biotec Company Details
Table 92. Miltenyi Biotec Business Overview
Table 93. Miltenyi Biotec Humanized Immune System (HIS) Models Product
Table 94. Miltenyi Biotec Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 95. Miltenyi Biotec Recent Development
Table 96. BioDuro Company Details
Table 97. BioDuro Business Overview
Table 98. BioDuro Humanized Immune System (HIS) Models Product
Table 99. BioDuro Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 100. BioDuro Recent Development
Table 101. GemPharmatech Company Details
Table 102. GemPharmatech Business Overview
Table 103. GemPharmatech Humanized Immune System (HIS) Models Product
Table 104. GemPharmatech Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 105. GemPharmatech Recent Development
Table 106. Shanghai Model Organisms Company Details
Table 107. Shanghai Model Organisms Business Overview
Table 108. Shanghai Model Organisms Humanized Immune System (HIS) Models Product
Table 109. Shanghai Model Organisms Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 110. Shanghai Model Organisms Recent Development
Table 111. Biocytogen Company Details
Table 112. Biocytogen Business Overview
Table 113. Biocytogen Humanized Immune System (HIS) Models Product
Table 114. Biocytogen Revenue in Humanized Immune System (HIS) Models Business (2020-2025) & (US$ Million)
Table 115. Biocytogen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Humanized Immune System (HIS) Models Picture
Figure 2. Global Humanized Immune System (HIS) Models Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Humanized Immune System (HIS) Models Market Share by Type: 2024 VS 2031
Figure 4. Mouse Features
Figure 5. Rat Features
Figure 6. Global Humanized Immune System (HIS) Models Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Humanized Immune System (HIS) Models Market Share by Application: 2024 VS 2031
Figure 8. Research Institutes Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Humanized Immune System (HIS) Models Report Years Considered
Figure 11. Global Humanized Immune System (HIS) Models Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Humanized Immune System (HIS) Models Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Humanized Immune System (HIS) Models Market Share by Region: 2024 VS 2031
Figure 14. Global Humanized Immune System (HIS) Models Market Share by Players in 2024
Figure 15. Global Humanized Immune System (HIS) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Humanized Immune System (HIS) Models Revenue in 2024
Figure 17. North America Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 19. United States Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 23. Germany Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Ireland Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Humanized Immune System (HIS) Models Market Share by Region (2020-2031)
Figure 31. China Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia & New Zealand Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 39. Mexico Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Humanized Immune System (HIS) Models Market Share by Country (2020-2031)
Figure 43. Israel Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Humanized Immune System (HIS) Models Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Charles River Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 47. Taconic Biosciences Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 48. Inotiv Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 49. Jackson Laboratory Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 50. Janvier Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 51. Crown Bioscience Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 52. GenOway Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 53. Oncodesign Services Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 54. Champions Oncology Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 55. Miltenyi Biotec Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 56. BioDuro Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 57. GemPharmatech Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 58. Shanghai Model Organisms Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 59. Biocytogen Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232